“COVID-19 Vaccine Update” by Dr. Shobha Swaminathan, University Hospital, Newark NJ
Dr. Swaminathan discusses the various strategies for developing vaccines, particularly the mRNA approach employed by Moderna and Pfizer/Biontech—the first two pharmaceutical companies to release vaccines. She also discusses vaccine efficacy, allergic reactions and contraindications for pregnant women. Note: Slides appearing in the video differ slightly from those available for download. (Running time: 23 minutes, 51 seconds | Slides 24-49)
Presentation Outline
Use the timestamps below.
00:00 | Slide 24 | Bio of Shobha Swaminathan, MD, Director of HIV Programs, University Hospital, Newark, NJ, Associate Professor of Medicine, Rutgers New Jersey Medical School
01:04 | Slide 24 | Start of presentation
Overview
01:17 | Slide 26 | SARS CoV-2, infections and deaths
01:47 | Slide 27 | Why is this important in minority communities (chart)
Vaccine strategies
01:53 | Slide 28 | Vaccine strategies for SARS CoV-2
04:23 | Slide 29 | Current phase 3 studies (not shown in webinar video)
08:10 | Slide 30 | mRNA approaches
09:23 | Slide 31 | mRNA vaccines (graphic)
The Moderna mRNA-1273 vaccine
11:20 | Slide 32 | Moderna mRNA-1273 vaccine
11:56 | Slide 33 | Moderna mRNA-1273 vaccine phase 3 COVE study
12:30 | Slide 34 | COVE study demographics
12:56 | Slide 35 | Adverse events
13:45 | Slide 36 | Vaccine efficacy
14:19 | Slide 37 | Other key points
The Pfizer/BionTech NBT162b2 vaccine
15:12 | Slide 38 | Pfizer/BionTech BNT162b2 vaccine
15:38 | Slide 39 | Phase 3 clinical study
15:55 | Slide 40 | Local and systemic reactions
16:47 | Slide 41 | Vaccine efficacy
17:37 | Slide 42 | Allergic reactions
18:13 | Slide 43 | Allergic reactions (2)
Recommendations and precautions
18:59 | Slide 44 | Other key points
19:04 | Slide 45 | Pregnant women
20:44 | Slide 46 | CDC recommendations*
21:23 | Slide 47 | Ongoing monitoring
22:15 | Slide 48 | Continuing precautions
22:46 | How to sign-up for the vaccine in New Jersey*
23:41 | Slide 49 | Research team and contact information
*Not available in slides distributed for download
Downloadable Resources
Presentations and other resources related to the webinar.
